These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8060761)

  • 1. Glucocorticoids.
    Kimberly RP
    Curr Opin Rheumatol; 1994 May; 6(3):273-80. PubMed ID: 8060761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A histomorphometric long-term longitudinal study of trabecular bone loss in glucocorticoid-treated patients: prednisone versus deflazacort.
    LoCascio V; Ballanti P; Milani S; Bertoldo F; LoCascio C; Zanolin EM; Bonucci E
    Calcif Tissue Int; 1998 Mar; 62(3):199-204. PubMed ID: 9501951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of pulse corticosteroid therapy for juvenile dermatomyositis.
    Paller AS
    Pediatr Dermatol; 1996; 13(4):347-8. PubMed ID: 8844758
    [No Abstract]   [Full Text] [Related]  

  • 4. Evolution of steroids and their value in the control of rheumatic disease.
    Polley HF
    Mayo Clin Proc; 1970 Jan; 45(1):1-12. PubMed ID: 4312402
    [No Abstract]   [Full Text] [Related]  

  • 5. [Glucocorticoids and risk of osteoporosis. On the problem of equivalent dose of desirable and undesirable effects of various glucocorticoids, exemplified by deflazacort].
    Rotenberger J; Köbberling J
    Med Klin (Munich); 1993 Jul; 88(7):432-7. PubMed ID: 8377721
    [No Abstract]   [Full Text] [Related]  

  • 6. [Problems in symptomatic therapy of rheumatic diseases with glucocorticoids and nonsteroidal antirheumatic agents].
    Mathies H
    Internist (Berl); 1979 Sep; 20(9):414-25. PubMed ID: 387649
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucocorticoid osteoporosis.
    Sambrook PN
    Curr Pharm Des; 2002; 8(21):1877-83. PubMed ID: 12171526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
    Werth VP
    Arch Dermatol; 1996 Dec; 132(12):1435-9. PubMed ID: 8961871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of cytokines for bone loss--are there possible interventions?].
    Scharla SH
    Z Rheumatol; 2001 Apr; 60(2):104-6. PubMed ID: 11383043
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of prednisone and deflazacort on vertebral bone mass.
    Gennari C; Imbimbo B
    Calcif Tissue Int; 1985 Dec; 37(6):592-3. PubMed ID: 3937579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: An observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts.
    Ruiz-Irastorza G; Ugarte A; Saint-Pastou Terrier C; Lazaro E; Iza A; Couzi L; Saenz R; Richez C; Porta S; Blanco P
    Autoimmun Rev; 2017 Aug; 16(8):826-832. PubMed ID: 28564619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current aspects of glucocorticoid therapy of rheumatic diseases. Pulse-therapy].
    Solovyev SK; Ivanova MM
    Ter Arkh; 2009; 81(6):73-8. PubMed ID: 19663198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Problems in evaluating dose equivalences of glucocorticoids.
    Köbberling J; Rotenberger J
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):434-6. PubMed ID: 1490770
    [No Abstract]   [Full Text] [Related]  

  • 14. Intact parathyroid hormone levels are not elevated in glucocorticoid-treated subjects.
    Paz-Pacheco E; Fuleihan GE; LeBoff MS
    J Bone Miner Res; 1995 Nov; 10(11):1713-8. PubMed ID: 8592948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.
    Olgaard K; Storm T; van Wowern N; Daugaard H; Egfjord M; Lewin E; Brandi L
    Calcif Tissue Int; 1992 Jun; 50(6):490-7. PubMed ID: 1525702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids.
    Spies CM; Strehl C; van der Goes MC; Bijlsma JW; Buttgereit F
    Best Pract Res Clin Rheumatol; 2011 Dec; 25(6):891-900. PubMed ID: 22265268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of glucocorticoids on calcium absorption and bone mass.
    Gennari C
    Br J Rheumatol; 1993 May; 32 Suppl 2():11-4. PubMed ID: 8495275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raloxifene for prevention of glucocorticoid-induced bone loss: a 12-month randomised double-blinded placebo-controlled trial.
    Mok CC; Ying KY; To CH; Ho LY; Yu KL; Lee HK; Ma KM
    Ann Rheum Dis; 2011 May; 70(5):778-84. PubMed ID: 21187295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
    Cacoub P; Chemlal K; Khalifa P; Wechsler B; De Gennes C; Belmatoug N; Cohen P; Ziza JM; Verdoncq B; Piette JC
    J Rheumatol; 2001 Nov; 28(11):2474-9. PubMed ID: 11708421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of different bone markers with bone density in patients with rheumatic diseases on glucocorticoid therapy.
    Loddenkemper K; Bohl N; Perka C; Burmester GR; Buttgereit F
    Rheumatol Int; 2006 Feb; 26(4):331-6. PubMed ID: 15887044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.